Mohr Marketing’s “Medical-First” Depo-Provera program screens for confirmed meningioma diagnoses, ensuring firms receive valid, exclusive mass tort cases.
As patient interest in regenerative medicine accelerates nationwide and regulatory scrutiny continues to intensify, Hyagen ...
About the Author: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA ...
Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...
The Food and Drug Administration (FDA) lacks certain authorities and is persistently underresourced to fulfill its mission of protecting the public by ensuring that foods are safe, wholesome, sanitary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results